BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 22739265)

  • 21. Effects of hydroxyurea and aphidicolin on phosphorylation of ataxia telangiectasia mutated on Ser 1981 and histone H2AX on Ser 139 in relation to cell cycle phase and induction of apoptosis.
    Kurose A; Tanaka T; Huang X; Traganos F; Dai W; Darzynkiewicz Z
    Cytometry A; 2006 Apr; 69(4):212-21. PubMed ID: 16528719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sodium salicylate acts through direct inhibition of phosphoinositide 3-kinase-like kinases to modulate topoisomerase-mediated DNA damage responses.
    Fan JR; Huang TH; Wen CY; Shen TL; Li TK
    Eur J Pharmacol; 2010 Jul; 638(1-3):13-20. PubMed ID: 20406630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ionizing radiation can induce GSK-3beta phosphorylation and NF-kappaB transcriptional transactivation in ATM-deficient fibroblasts.
    Kwon O; Kim KA; He L; Kim SO; Kim MS; Cha EY; Yoon BD; Sok DE; Jung M; Ahn JS; Kim BY
    Cell Signal; 2008 Apr; 20(4):602-12. PubMed ID: 18243662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of ATM and 53BP1 as predictive markers in cervical cancer.
    Roossink F; Wieringa HW; Noordhuis MG; ten Hoor KA; Kok M; Slagter-Menkema L; Hollema H; de Bock GH; Pras E; de Vries EG; de Jong S; van der Zee AG; Schuuring E; Wisman GB; van Vugt MA
    Int J Cancer; 2012 Nov; 131(9):2056-66. PubMed ID: 22323184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM.
    Hickson I; Zhao Y; Richardson CJ; Green SJ; Martin NM; Orr AI; Reaper PM; Jackson SP; Curtin NJ; Smith GC
    Cancer Res; 2004 Dec; 64(24):9152-9. PubMed ID: 15604286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ATM-dependent and -independent dynamics of the nuclear phosphoproteome after DNA damage.
    Bensimon A; Schmidt A; Ziv Y; Elkon R; Wang SY; Chen DJ; Aebersold R; Shiloh Y
    Sci Signal; 2010 Dec; 3(151):rs3. PubMed ID: 21139141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
    Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
    Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiation-induced radioresistance in muscle cells.
    Latella L; Lukas J; Simone C; Puri PL; Bartek J
    Mol Cell Biol; 2004 Jul; 24(14):6350-61. PubMed ID: 15226436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphorylation of p53 on Ser15 during cell cycle caused by Topo I and Topo II inhibitors in relation to ATM and Chk2 activation.
    Zhao H; Traganos F; Darzynkiewicz Z
    Cell Cycle; 2008 Oct; 7(19):3048-55. PubMed ID: 18802408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ATM-dependent hyper-radiosensitivity in mammalian cells irradiated by heavy ions.
    Xue L; Yu D; Furusawa Y; Cao J; Okayasu R; Fan S
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):235-43. PubMed ID: 19695441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ATM inhibitor KU-55933 increases the TMZ responsiveness of only inherently TMZ sensitive GBM cells.
    Nadkarni A; Shrivastav M; Mladek AC; Schwingler PM; Grogan PT; Chen J; Sarkaria JN
    J Neurooncol; 2012 Dec; 110(3):349-57. PubMed ID: 23054561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression.
    Kang J; Ferguson D; Song H; Bassing C; Eckersdorff M; Alt FW; Xu Y
    Mol Cell Biol; 2005 Jan; 25(2):661-70. PubMed ID: 15632067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ATM- and NEMO-dependent ELKS ubiquitination coordinates TAK1-mediated IKK activation in response to genotoxic stress.
    Wu ZH; Wong ET; Shi Y; Niu J; Chen Z; Miyamoto S; Tergaonkar V
    Mol Cell; 2010 Oct; 40(1):75-86. PubMed ID: 20932476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ataxia telangiectasia mutated activation by transcription- and topoisomerase I-induced DNA double-strand breaks.
    Sordet O; Redon CE; Guirouilh-Barbat J; Smith S; Solier S; Douarre C; Conti C; Nakamura AJ; Das BB; Nicolas E; Kohn KW; Bonner WM; Pommier Y
    EMBO Rep; 2009 Aug; 10(8):887-93. PubMed ID: 19557000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cellular ataxia telangiectasia-mutated kinase promotes epstein-barr virus lytic reactivation in response to multiple different types of lytic reactivation-inducing stimuli.
    Hagemeier SR; Barlow EA; Meng Q; Kenney SC
    J Virol; 2012 Dec; 86(24):13360-70. PubMed ID: 23015717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of ataxia telangiectasia mutated kinase activity enhances TRAIL-mediated apoptosis in human melanoma cells.
    Ivanov VN; Zhou H; Partridge MA; Hei TK
    Cancer Res; 2009 Apr; 69(8):3510-9. PubMed ID: 19351839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic inhibition of ATM kinase provides a strategy for glioblastoma multiforme radiosensitization and growth control.
    Golding SE; Rosenberg E; Adams BR; Wignarajah S; Beckta JM; O'Connor MJ; Valerie K
    Cell Cycle; 2012 Mar; 11(6):1167-73. PubMed ID: 22370485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcription-dependent activation of ataxia telangiectasia mutated prevents DNA-dependent protein kinase-mediated cell death in response to topoisomerase I poison.
    Sakasai R; Teraoka H; Takagi M; Tibbetts RS
    J Biol Chem; 2010 May; 285(20):15201-15208. PubMed ID: 20304914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TRF2 dysfunction elicits DNA damage responses associated with senescence in proliferating neural cells and differentiation of neurons.
    Zhang P; Furukawa K; Opresko PL; Xu X; Bohr VA; Mattson MP
    J Neurochem; 2006 Apr; 97(2):567-81. PubMed ID: 16539655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxicity and mitochondrial apoptosis induced by etoposide in melanoma cells.
    Rudolf K; Cervinka M; Rudolf E
    Cancer Invest; 2009 Aug; 27(7):704-17. PubMed ID: 19488905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.